J Korean Soc Transplant.  2012 Sep;26(3):207-209. 10.4285/jkstn.2012.26.3.207.

Verruca Eradication Following Conversion to Sirolimus in a Renal Transplant Recipient after Longstanding Cyclosporine A Treatment

• Joo DJ
• Kim SH
• Huh KH
• Kim YS

• KMID: 2003537
• DOI: http://doi.org/10.4285/jkstn.2012.26.3.207

Abstract

We present the case of a 50-year-old male kidney transplant recipient whose verruca skin warts completely disappeared after conversion of immunosuppressive treatment from cyclosporine A to sirolimus. Before conversion, the patient underwent three sessions of cryotherapy, but this treatment failed to produce noticeable improvement in wart number or severity. In this case of a transplant recipient under CsA-based immunosuppression, change of immunosuppressive treatment to sirolimus produced dramatic improvement in the elimination of verruca warts.

Keyword

Sirolimus; Warts; Kidney transplantation

MeSH Terms

Cryotherapy
Cyclosporine
Humans
Immunosuppression
Kidney
Kidney Transplantation
Male
Middle Aged
Sirolimus
Skin
Transplants
Warts
Cyclosporine
Sirolimus

Figure

• 

  Fig. 1 Skin lesions before and after sirolimus conversion. The patient complained of severe skin warts on the hands and feet (A, B). Four months after conversion from cyclosporine A to sirolimus, the skin lesions dramatically disappeared (C, D).

Reference

1. Moloney FJ, Keane S, O'Kelly P, Conlon PJ, Murphy GM. The impact of skin disease following renal transplantation on quality of life. Br J Dermatol. 2005. 153:574–578.

2. McLelland J, Rees A, Williams G, Chu T. The incidence of immunosuppression-related skin disease in long-term transplant patients. Transplantation. 1988. 46:871–874.

3. Pruvost C, Penso-Assathiany D, Bachot N, Lang P, Roujeau JC. Risk factors for cutaneous wart onset in transplant recipients. Ann Dermatol Venereol. 2002. 129:291–293.

4. Barba A, Tessari G, Talamini G, Chieregato GC. Analysis of risk factors for cutaneous warts in renal transplant recipients. Nephron. 1997. 77:422–426.

5. Marcén R. Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection. Drugs. 2009. 69:2227–2243.

6. Hampton T. Skin cancer's ranks rise: immunosuppression to blame. JAMA. 2005. 294:1476–1480.

7. Serdar ZA, Eren PA, Canbakan M, Turan K, Tellioglu G, Gülle S, et al. Dermatologic findings in renal transplant recipients: possible effects of immunosuppression regimen and p53 mutations. Transplant Proc. 2010. 42:2538–2541.

8. Kostaki M, Venetz JP, Nseir G, Meylan P, Sahli R, Pascual M, et al. Giant warts in a kidney transplant patient: regression with sirolimus. Br J Dermatol. 2010. 162:1148–1150.

9. Shahidi S, Moeinzadeh F, Mohammadi M, Gholamrezaei A. Sirolimus-based immunosuppression for treatment of cutaneous warts in kidney transplant recipients. Iran J Kidney Dis. 2011. 5:351–353.

10. Dharancy S, Catteau B, Mortier L, Boleslawski E, Declerck N, Canva V, et al. Conversion to sirolimus: a useful strategy for recalcitrant cutaneous viral warts in liver transplant recipient. Liver Transpl. 2006. 12:1883–1887.

11. Di Benedetto F, Di Sandro S, De Ruvo N, Montalti R, Ballarin R, Guerrini GP, et al. First report on a series of HIV patients undergoing rapamycin monotherapy after liver transplantation. Transplantation. 2010. 89:733–738.

12. Gallego R, Henriquez F, Oliva E, Camacho R, Hernández R, Hortal L, et al. Switching to sirolimus in renal transplant recipients with hepatitis C virus: a safe option. Transplant Proc. 2009. 41:2334–2336.

13. Bonatti H, Aigner F, De Clercq E, Boesmueller C, Widschwendner A, Larcher C, et al. Local administration of cidofovir for human papilloma virus associated skin lesions in transplant recipients. Transpl Int. 2007. 20:238–246.

14. Sayin B, Karakayali H, Colak T, Sevmis S, Pehlivan S, Demirhan B, et al. Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion. Transplant Proc. 2009. 41:2789–2793.

15. Lee HS, Huh KH, Kim YS, Kim MS, Kim HJ, Kim SI, et al. Sirolimus-induced pneumonitis after renal transplantation: a single-center experience. Transplant Proc. 2012. 44:161–163.